Implants have been embedded into the first patient as part of a new study to test a treatment developed in the Netherlands ...

DARPA's latest program, RESTORE, aims to supercharge sleep deprived soldiers on as little as three hours of rest.

The study will evaluate Sinaptica’s SinaptiStim in delivering simultaneous transcranial magnetic and alternating current ...

Overview of the Migraine Drugs MarketThe global Migraine Drugs Market is valued at $6.37 billion in 2024 and is projected to ...

Integer Holdings Corp (ITGR) reports robust sales growth and strategic acquisitions, despite facing challenges with tariffs and gross margins.

Australian MedTech company Ceretas has successfully secured $1 million in seed funding to advance its low-cost, portable and non-invasive ultrasound ...

Valencia will seek to leverage the investment as well as Surek’s leadership experience to drive commercialization of its ...

Q4 2024 Management View CEO Joe Dziedzic announced that Integer Holdings achieved 11% sales growth in Q4 2024 on both an organic and reported basis, contributing to a full-year growth of 10%. Adjusted ...

Valencia Technologies announced today that it received a strategic investment totaling up to $35 million and appointed a new ...

Sinaptica Therapeutics, Inc., a clinical-stage company leading the development of a new class of personalized neuromodulation ...

NaviFUS Corp. is revolutionizing brain disorder treatments through ultrasound-based solutions, leveraging Taiwan's advanced chip technology. By integrating ICT capabilities into high-end medical ...

Nyxoah SA, a medical technology company that develops breakthrough treatment alternatives for obstructive sleep apnoea (OSA) through neuromodulation, announced the commercial launch of its Genio ...